|

MBS8(1V270) and pembrolizumab combination Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • MonTa Biosciences ApS1

Indications

  • Uveal Melanoma, Metastatic1
  • Cutaneous Melanoma1
  • Advanced Solid Tumor1
  • Cancer1

Other1 trial

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.